01682oam 2200457 450 991071343400332120200430092947.0(CKB)5470000002501315(OCoLC)640889568(EXLCZ)99547000000250131520100613d1999 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierPrescription drug benefits: impact of Medicare HMO's use of formularies on beneficiaries testimony before the Special Committee on Aging, U.S. Senate /statement of William J. ScanlonWashington, D.C. :United States General Accounting Office,1999.1 online resource (7 pages)Testimony ;GAO/T-HEHS-99-171"For release on delivery expected at 2:30 p.m. Tuesday, July 20, 1999."Includes bibliographical references.Prescription drug benefitsDrugsUnited StatesCost controlHealth maintenance organizationsUnited StatesMedicarePrescription pricingUnited StatesDrugsCost control.Health maintenance organizationsMedicare.Prescription pricingScanlon William J.United States.Congress.Senate.Special Committee on Aging,AD#AD#OCLCQGPOBOOK9910713434003321Prescription drug benefits: impact of Medicare HMO's use of formularies on beneficiaries3450772UNINA